Cytokines have been implicated s immunological effector molecules that mediate beta cell destruction asciated with insulin-dependent diabetes mellitus. In this report we demonstrate that the cytokine combination of human recombinant interieukin lp (IL-1*), tumor necrosis factor a (TNF-a), and interferon y (IFN-y) induces the formation of nitric oxide by human islets. This combination of cytokines stimulates both the formation of the nitric oxide derivative, nitrite, and the accumulation of cGMP by human iWets. The nitric oide synthase inhibitor NG.monomethyl-L-argIne prevents formation of both cGMP and nitrite. IL-1,B and IFN-y are sufcient to induce nitric oide formation by human islets, whereas TNF-a potentiates nitrite production. This combination of cytokines (IL-1f3, TNF-a, and IFN-y) also influences insulin secretion by human idets. Pretreatment of human iWets with low concentrations of this cytokne combination (IL-lp at 15 units/ml, 0.7 nM TNF-a, and IFN-y at 150 units/ml) appears to slightly stimulate insulin secretion. Higher concentrations (IL-l1 at 75 units/nl, 3.5 nM TNF-a, and IFN-yat 750 units/ml) inhibit inlin secretion from human islets, and the inhibitory effect is prevented by NG-monomethyl-L-argine. This higher concentration of cytokines also induces the formation of an electron paramagnetic resonance-detectable g = 2.04 axial feature by human islets that is characteristic of the formation of an iron-diho-dinitrosyl complex. The formation of this complex is prevented by NG-monomethyl-L-arginine, thus confirming that this cytokine combination induces the formation of nitric oxide by human islets. These results indicate that nitric oxide mediates the inhibitory effects of cytoldnes on glucosestimulated insulin secretion by human Wets and suggest that nitric oidde may participate in beta-cell dysfunction associated with insulin-dependent diabetes mellitus.
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Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease characterized by specific destruction of the pancreatic islet beta cell (1) . The destruction of beta cells is believed to be mediated by infiltrating lymphocytes. The ability of T cells to adoptively transfer diabetes in diabetesprone BB rats (2) and in the NOD mouse indicates that T cells participate in beta-cell destruction (3) . Cytokines, released by infiltrating lymphocytes, have also been implicated as possible mediators of beta-cell destruction. Pretreatment of isolated rat islets with the cytokine human recombinant interleukin 1,B (IL-1*8) results in a concentration-and timedependent inhibition of glucose-stimulated insulin secretion that is followed by islet destruction after prolonged exposures to this cytokine (4, 5) .
The free-radical nitric oxide has been implicated as the cellular effector molecule that mediates the inhibitory and cytotoxic effects of IL-1,3 on rat islets (6) . Pretreatment of rat islets for 18-24 hr with IL-1lB results in nearly complete inhibition of glucose-stimulated insulin secretion that is prevented by the nitric oxide synthase inhibitors, NG-nitro-Larginine methylester and N0-monomethyl-L-arginine (NMMA) (7) (8) (9) . These inhibitors also prevent IL-l-induced nitrite production, cGMP accumulation, and the formation of electron paramagnetic resonance (EPR)-detectable ironnitrosyl complexes by rat islets (9, 10) . Nitric oxide appears to mediate the inhibitory effects of IL-1.3 by targeting intracellular iron-sulfur centers, resulting in inhibition of the enzymatic activity of mitochondrial iron-sulfur-containing enzymes (8) (9) (10) .
Nitric oxide is the product of the oxidation of L-arginine to L-citrulline by nitric oxide synthase. Two isoforms of nitric oxide synthase have been characterized (11, 12) . Cytokines and endotoxin induce the expression of one isoform of nitric oxide synthase, which generates high levels of nitric oxide that is cytotoxic or cytostatic to target cells (13, 14) . Expression of the other isoform is constitutive, and the low levels of nitric oxide produced by this isoform function as a signaling molecule (15, 16) . Although the constitutive isoform of nitric oxide synthase has been purified from human brain (17) , only a limited number of studies have provided evidence for the presence of the inducible isoform in human tissue. Isolated human monocytes have been shown to produce nitrite in response to lipopolysaccharide (18) , and isolated human hepatocytes produce nitric oxide after pretreatment with a mixture of cytokines and endotoxin (19) . Also, Hibbs et al. (20) , have shown increased levels ofnitrate in both serum and urine in patients after IL-2 therapy, and Ochoa et al. (21, 22) have shown increased nitrogen oxide levels in patients after trama, during sepsis, and after human tumor immunotherapy.
The presence of both isoforms of nitric oxide synthase has been confirmed in rat islets (7-10, 23, 24) chem. All other chemicals were from commercially available sources.
Human Islet Isolation and Cytokine Exposure. Human islets, provided by David Scharp (Washington University School of Medicine), were isolated by collagenase digestion, as described (25) . Human islets were either cultured for 7 days in complete CMRL-1066 tissue culture medium (CMRL-1066/2 mM L-glutamine/10% heat-inactivated fetal bovine serum, penicillin at 100 units/ml/streptomycin at 100 &g/ ml/25 mM Hepes, pH 7.4) at 25°C, cryopreserved, or used freshly after isolation; CMRL-1066 contains 0.3 mM L-arginine. No apparent differences in nitric oxide production by human islets were seen under any ofthese culture conditions. Human islets were incubated for 24-48 hr at 37°C in complete CMRL-1066 before the initiation of experiments. After this culture period, human islets were washed in 2.5 ml of complete CMRL-1066 three times and then counted into Petri dishes containing 1 ml or 2.5 ml of complete CMRL-1066. Cytokines were added to final concentrations as indicated in figure legends, and the islets were incubated for various periods under an atmosphere of 95% air/5% CO2 at 370C.
Glucose-Induced Insulin Secretion. After the culture period with cytokines human islets were washed three times ( 
RESULTS AND DISCUSSION
Because IL-l-induced nitric oxide production has been implicated as the cellular effector molecule that mediates rat islet dysfunction, we examined the effects of IL-1,B on nitrite production by human islets. At a concentration (15 units/ml) that induces islet dysfunction and nitric oxide production by rat islets, IL-1 does not appear to induce the formation of nitrite by human islets (Fig. 1) . At this concentration IL-1,B also has no effect on glucose-stimulated insulin secretion by human islets (data not shown). However the combination IL-1p3 and IFN-y induces the formation of nitrite by human islets after a 24-hr exposure. TNF-a potentiates IL-1l-and IFN--induced nitric oxide production by human islets. Individually, IL-1p, TNF-a, or IFN-y each fails to induce the formation of nitric oxide by human islets. The requirement for two cytokine signals is similar to that for cytokineinduced nitric oxide formation by several cell types including macrophages, hepatocytes, and endothelial cells (11) , but it is in contrast to the individual effects of IL-13 on nitric oxide production by rat islets (6) .
To further confirm that cytokines induce the formation of nitric oxide, we examined the effects of IL-1(3, TNF-a, and IFN-y on nitrite formation and the accumulation of cGMP by human islets. cGMP accumulation increases in response to nitric oxide activation of soluble guanylate cyclase (16) . Table 1 shows that pretreatment of human islets for 24 and 48 hr with IL-1,8 at 15 units/ml, 0.7 nM TNF-a, and IFN-,yat 150 units/ml results in the production of nitrite and in the accumulation of cGMP, both of which are prevented by NMMA. Aminoguanidine, a recently identified selective inhibitor of the inducible isoform of nitric oxide synthase (27) , also prevents nitrite formation by human islets.
Because nitric oxide has been implicated as an effector molecule that mediates the inhibitory effects of IL-1j on glucose-stimulated insulin secretion by rat islets, we examined the effects of cytokine-induced nitric oxide production on insulin secretion by human islets (Fig. 2) . Pretreatment of human islets for 24 hr with IL-1,B at 15 units/ml, 0.7 nM TNF-a, and IFN-y at 150 units/ml slightly stimulates glucose-induced insulin secretion. Although this stimulation is not statistically significant, it is similar to the effects produced by low concentrations of IL-1 on glucose-induced (28) . The ability of this cytokine combination to stimulate insulin secretion at these (low) concentrations does not appear to be related to the production of nitric oxide, as NMMA has little effect on this stimulation. NMMA also has no effect on IL-1-induced stimulation of insulin secretion by rat islets, further suggesting that nitric oxide formation does not participate in this stimulation (8, 9) . Evidence suggests that IL-l3-induced stimulation of insulin secretion by rat islets may be related to an increase in the level of proinsulin biosynthesis (29) . The inability of nitric oxide to inhibit insulin secretion at these cytokine concentrations (IL-1l3 at 15 units/ml, 0.7 nM TNF-a, and IFN-yat 150 units/ml) may reflect the possibility that a threshold level of nitric oxide is required to inhibit insulin secretion by human islets. To determine a concentration of these cytokines that causes the maximum production of nitric oxide, human islets were incubated for 24 tions of these cytokines that induce the formation of nitric oxide by human islets (IL-1f at 15 units/mi, 0.7 nM TNF-a, and IFN-^y at 150 units/mi). Fig. 3 demonstrates that pretreatment of human islets for 24 hr with a concentration of each cytokine that is five times higher than the lx concentration (IL-lp at 75 units/mi, 3.5 nM TNF-a, and IFN-y at 750 units/mi) results in p4.5-fold increase in nitrite level. The level of nitrite produced under these conditions (~5 pmol per islet) is similar in magnitude to the level of nitrite produced by rat islets in response to IL-1,B at 5 units/mi (6) (7) (8) (9) . In addition, NMMA prevents nitrite formation in response to this concentration of cytokines.
The effects of these higher cytokine concentrations (IL-1,B at 75 units/mi, 3.5 nM TNF-a, and IEN-yat 750 units/mi) on glucose-induced insulin secretion from human islets are shown in Fig. 4 . Pretreatment of human islets for 24 hr with this cytokine combination results in a potent inhibition of glucose-stimulated insulin secretion. Nitric oxide appears to participate in cytokine-induced inhibition of insulin secretion because NMMA partially prevents the inhibitory effects of these cytokines on insulin secretion by human islets. However, NMMA does not completely prevent cytokine-induced inhibition of insulin secretion by human islets, suggesting that other factors may also be involved. These factors may include oxygen free radicals that have been implicated as destructive agents in cytoksine-induced islet-cell lysis (30).
. washed, and glucose-stimulated insulin secretion was determined as described. Results are the average ± SEM of two individual experiments containing four replicates per condition. Statistically significant inhibition of insulin secretion (P < 0.01) was determined by ANOVA and indicated (*).
The individual effects of these cytokines on nitrite formation, at concentrations required to inhibit glucose-stimulated insulin secretion by human islets, were also examined. Fig.  5 shows that individually neither IL-1# at 75 units/ml, 3.5 nM TNF-a, nor IFN-y at 750 units/ml induced the formation of nitrite after a 24-hr culture period. However, IL-lp and IFN-yin combination induced a 5-fold increase in the level of nitrite produced, as compared with untreated control islets. TNF-a further stimulates the production of nitrite by these two cytokines. These results are completely consistent with the individual effects of these cytokines at 5-fold lower concentrations (Fig. 1) .
To confirm that IL-1lB at 75 units/ml, 3.5 nM TNF-a, and IFN-y at 750 units/ml induce the formation of nitric oxide by human islets, the effect of this cytokine combination on the formation of EPR-detectable iron-nitrosyl complexes was examined. Fig. 6 shows that pretreatment of human islets for 18 hr with IL-1p8 at 75 units/ml, 3.5 nM TNF-a, and IFN-y at 750 units/ml induces the formation of an axial g = 2.04 feature that is characteristic of an iron-nitrosyl complex. The formation of an EPR-detectable g = 2.04 iron-nitrosyl complex has been used to confirm the formation of nitric oxide by activated macrophages (31, 32) , macrophage target cells (33) , rat islets (9, 10) , and the insulinoma cell line RINm5F (34) . NMMA prevents the formation of this axial feature, demonstrating the requirement for nitric oxide synthase activity. The simultaneous formation of nitrite from the same islets used for EPR spectroscopy was also examined. Cytokines stimulated an increase in nitrite production from an untreated control value of 0.3 + 0.2 pmol per islet to 2.05 ± 0.1 pmol per islet, and NMMA blocked this increase in nitrite formation. The formation of this iron-nitrosyl complex and the simultaneous formation of nitrite further confirm that cytokines induced the production of nitric oxide by human islets.
Data presented in this study indicate that human islets respond to cytokines in a concentration-dependent manner. Low concentrations of cytokines appear to slightly stimulate insulin secretion, whereas higher concentrations inhibit glucose-induced insulin secretion by human islets. This result is similar to the effects of IL-1,8 on insulin secretion by isolated rat islets (4, 5, 28) . Nitric oxide appears to participate in cytokine-induced inhibition of insulin secretion by human islets, because NMMA partially prevents these effects. These results provide evidence for the involvement of the free-radical nitric oxide in cytokine-induced human beta-cell dysfunction that occurs early in IDDM. The cellular mechanism by which nitric oxide mediates cytokine-induced inhibition of glucose-stimulated insulin secretion appears to be the result of iron-sulfur-center destruction of iron-sulfur-containing enzymes. The formation of EPR-detectable iron-nitrosyl complexes has been demonstrated to occur in macrophages, hepatocytes, and islets, under conditions in which mitochondrial electron transport at complexes 1 and 2, and mitochondrial aconitase activity are impaired (6, 14) . Also glucose-stimulated insulin secretion is specifically sensitive to impaired mitochondrial function, as glucose metabolism is absolutely required for insulin secretion. These results implicate nitric oxide-mediated mitochondrial iron-sulfur protein destruction as the mechanism of cytokine-induced impairment of the insulin secretory response by human islets.
IDDM is characterized by lymphocytic infiltration into the islet. This cellular infiltrate contains macrophages and monocytes that produce IL-1 and TNF, and T cells that produce IFN-y. The release of these cytokines may induce the expression of nitric oxide synthase by human islets, as well as by macrophages. We have recently demonstrated that IL-1,B induces the formation of nitric oxide by the rat islet beta cell (34) , and many laboratories have reported that TNF and IFN--y induce the formation of nitric oxide by macrophages. In addition, activated rat macrophages have been shown to kill syngeneic islet cells by L-arginine-dependent nitric oxide formation (35) , and NMMA appears to partially prevent low-dose streptozotocin-induced diabetes in male CBA mice (36, 37) . Because nitric oxide appears to mediate both cytokine-induced inhibition of insulin secretion by human and rat islets and rat islet cell lysis, it is tempting to implicate nitric oxide as an effector molecule that may participate in beta-cell dysfunction and destruction observed in IDDM. Cytokine-induced nitric oxide formation does not preclude the involvement of cytotoxic T cells that are believed to be required for autoimmune beta-cell destruction. The production of cytotoxic amounts of nitric oxide by beta cells, and possibly macrophages, may function in concert with T cells, resulting in beta-cell destruction.
